Goodwin Advises Vidi Capital on Acquisition of IM86 Pictavix

Goodwin advised Vidi Capital in the acquisition of the IM86 Pictavix group. The transaction involves Vidi Capital's purchase of IM86 Pictavix, a key player in medical imaging. With this backing, Vidi Capital confirms its position as a major participant in diagnostic and therapeutic medical imaging in France. Created in 2022 by radiologists from the Vidi network, the largest private radiology network in France with nearly 1,250 members, Vidi Capital offers an innovative model to consolidate independent medical imaging providers and seeks to guarantee high-quality care while addressing the sector's principal challenges amid significant restructuring. IM86 Pictavix is based in Poitiers and brings together 19 radiologists and 90 employees across six imaging sites. The group performs several hundred thousand examinations per year and has established itself as a regional reference in the Vienne department through the quality of its equipment and the rigor of its diagnostic approach. Goodwin represented Vidi Capital with a team composed by: William Robert (partner, corporate); Sabine Bensaid (associate, corporate); Elea Poirée (legal counsel, corporate); Daphnée Rubcke (legal counsel, corporate); Charles-Henri de Gouvion Saint-Cyr (partner, tax); Paul Fournière (associate, tax); Adrien Paturaud (partner, financing); Alexander Hahn (associate, financing); Elisa Revel (associate, financing); and Jad Bezzari (associate, financing).

Goodwin Advises Vidi Capital on Acquisition of IM86 Pictavix

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads